{
    "Case ID": "022006",
    "Different Crime": [
        {
            "Crime Name": "Patent Infringement",
            "Crime Type": "Economic_Crimes_or_Fraud-related_Offenses",
            "legal_basis": [
                "Patented Medicines (Notice of Compliance) Regulations"
            ],
            "patent_validity": [
                "obvious chemical equivalent"
            ],
            "expert_testimony": [
                "Experts disagree on whether this constitutes an obvious chemical equivalent"
            ],
            "applicable_statute": [
                "Claim 6 of the Abbott Patent covers obvious chemical equivalents"
            ],
            "evidence_provided": [
                "solubility data from the Merck Index",
                "expert affidavits"
            ],
            "decision_outcome": [
                "The application was granted, prohibiting Nu-Pharm from receiving a Notice of Compliance until the patent expires"
            ],
            "cause_of_action": [
                "Abbott sought to prevent Nu-Pharm from marketing terazosin hydrochloride dihydrate before the patent expiration"
            ],
            "nature_of_offense": [
                "generic manufacturer cannot market a drug if it infringes on a valid patent"
            ]
        }
    ]
}